Article

Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers

2022-04-05

Abstract excerpt

<h4>Background: </h4> / Synopsis: Cholesterol plays an important role in sustaining tumor growth and metastasis in a large variety of cancers. New and powerful cholesterol-lowering drugs are being used in combination to treat cardiovascular diseases. Thus, it becomes intuitive to verify whether these drugs could be combined to induce a cholesterol shortage sufficient to impede tumor progression. Circulating levels...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a41d9c76-05f3-5816-a08d-11dbeacacbd2
DOI: 10.21203/rs.3.rs-1412728/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancersDOI 10.21203/rs.3.rs-1412728/v1Read

Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancersSemantic proximity Read

ANGPTL3 binds to PCSK9 to coordinately regulate intracellular lipid homeostasisSemantic proximity Read

PCSK9: From discovery to therapeutic applications.Semantic proximity Read

The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodiesSemantic proximity Read

Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL CholesterolSemantic proximity Read

Proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015).Semantic proximity Read

Elevated Plasma ACE2 and Shifted Ang 1-7/Ang II Ratios: A Novel Multi-Analyte Signature for Distinguishing Breast Cancer Patients from Healthy Controls—A Pilot Case-Control StudySemantic proximity Read

Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia: A One Center Study.Semantic proximity Read

Gender differences in the plasma profiles of PCSK9, soluble LDLR, total cholesterol, and triglycerides in patients with colorectal cancer liver metastases: diagnostic and prognostic implicationsSemantic proximity Read

Dual Control of LDL-cholesterol Levels by ANGPTL3 and ANGPTL8Semantic proximity Read

ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report.Semantic proximity Read

Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: functional regulation of LDLR levelsSemantic proximity Read